These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Subcutaneous implantation of pure crystalline estradiol pellets for conception control. Oettinger M; Barak S; Oettinger-Barak O; Ophira E Gynecol Obstet Invest; 2005; 59(3):119-25. PubMed ID: 15591820 [TBL] [Abstract][Full Text] [Related]
5. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception. Nelson AL J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701 [TBL] [Abstract][Full Text] [Related]
6. Depo-Provera use in an Australian metropolitan practice. Fraser IS; Dennerstein GJ Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553 [TBL] [Abstract][Full Text] [Related]
8. [Indications and medical survey of long acting progestatives used for contraception (author's transl)]. Molitor-peffer MP Contracept Fertil Sex (Paris); 1982 Oct; 10(10):665-8. PubMed ID: 12338449 [TBL] [Abstract][Full Text] [Related]
9. Where next with long-acting steroids? Potts DM; Siemens AJ IPPF Med Bull; 1984 Jun; 18(3):2-3. PubMed ID: 12266285 [TBL] [Abstract][Full Text] [Related]
19. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs. Prema K Contracept Deliv Syst; 1982 Jan; 3(1):39-46. PubMed ID: 12264126 [TBL] [Abstract][Full Text] [Related]
20. Effects of hormonal contraception on bone mineral density after 24 months of use. Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]